chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain in extremity
Clinical narrative: Sore arm; Headache; Tiredness; Nauseous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient received bnt162b2 (BNT162B2), administration date 27Feb2021 (Batch/Lot number: unknown) at the age of 69 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Diabetic" (unspecified if ongoing), notes: Verbatim: Diabetic; "High blood pressure" (unspecified if ongoing), notes: Verbatim: High blood pressure. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 27Feb2021, outcome "recovered" (2021), described as "Sore arm"; HEADACHE (non-serious) with onset 27Feb2021, outcome "recovered" (2021), described as "Headache"; FATIGUE (non-serious) with onset 27Feb2021, outcome "recovered" (2021), described as "Tiredness"; NAUSEA (non-serious) with onset 27Feb2021, outcome "not recovered", described as "Nauseous". Therapeutic measures were taken as a result of nausea.  Additional information: The only thing I took was like ginger ale for the nausea and Pepto-Bismol.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: it was beginning to kill his arm and then he held his arm like it was; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP).  An elderly male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose of vaccine), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 28Feb2021, outcome "unknown", described as "it was beginning to kill his arm and then he held his arm like it was".  Additional information included: The patient was an older man, who was maybe in his 80s or older, who got the vaccine from the girl who was warming the vials, and the man said that the first dose did not hurt him, but this second dose hurt, and it was beginning to kill his arm and then he held his arm like it was hurting.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Hyperhidrosis, Nausea
Clinical narrative: Fatigue; Dizziness; Nausea; slight headache; Dry heaves; broke out into a sweat; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 82 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Feb2021 09:30 (Lot number: EN6202) at the age of 82 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "motion sickness anyway" (unspecified if ongoing); "heart condition" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Fatigue"; DIZZINESS (non-serious), outcome "unknown", described as "Dizziness"; NAUSEA (non-serious), outcome "unknown", described as "Nausea"; HEADACHE (non-serious), outcome "unknown", described as "slight headache"; RETCHING (non-serious), outcome "unknown", described as "Dry heaves"; HYPERHIDROSIS (non-serious), outcome "unknown", described as "broke out into a sweat".   No follow-up attempts are possible . No further information is expected.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Retching
Clinical narrative: Fatigue; Dizziness; Nausea; slight headache; Dry heaves; broke out into a sweat; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 82 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Feb2021 09:30 (Lot number: EN6202) at the age of 82 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "motion sickness anyway" (unspecified if ongoing); "heart condition" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Fatigue"; DIZZINESS (non-serious), outcome "unknown", described as "Dizziness"; NAUSEA (non-serious), outcome "unknown", described as "Nausea"; HEADACHE (non-serious), outcome "unknown", described as "slight headache"; RETCHING (non-serious), outcome "unknown", described as "Dry heaves"; HYPERHIDROSIS (non-serious), outcome "unknown", described as "broke out into a sweat".   No follow-up attempts are possible . No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Malaise
Clinical narrative: This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A 79-year-old female patient received the 2nd dose of BNT162B2 (Comirnaty, batch/lot# unknown), at the age of 79, on Feb 12, 2021, single dose, for COVID-19 immunisation. No medical history reported. The patient took concomitant medications. Vaccination history included the 1st dose of BNT162B2 (Comirnaty, batch/lot# EL0142), on Jan 22, 2021, for COVID-19 immunisation. The patient reported extreme fatigue/tiredness and malaise (feeling unwell) onset 2021, with outcome of not recovered. Additional information: The patient only on blood pressure medication. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypoaesthesia, Lymphadenopathy, Pain, Paraesthesia
Clinical narrative: Achiness; Tired; lymph nodes were swollen; tingling and numbing kind of feeling; arm feels kind of swollen; tingling and numbing kind of feeling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Feb2021 09:30 (Batch/Lot number: unknown) at the age of 53 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Brand; Pfizer BioNTech, Dose=1, Location: right arm), administration date: 04Feb2021, when the patient was 53 years old, for Covid-19 Immunisation. The following information was reported: PAIN (non-serious), outcome "unknown", described as "Achiness"; FATIGUE (non-serious), outcome "unknown", described as "Tired"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "lymph nodes were swollen"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious), outcome "unknown" and all described as "tingling and numbing kind of feeling"; PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "arm feels kind of swollen". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information: Caller reported that she received the second dose of the Covid-19 Vaccine on Thursday 25Feb2021 at about 09:30. She had some symptoms for about 30 hours afterward that she said that she expected like the achiness and tired. On Friday evening, her lymph nodes were swollen under her left arm. That is where she got her shot, the left arm. Every day since since it is swollen, puffy, and painful to touch. She said that it is all the way down her arm, from her hand into her fingers, like a tingling and numbing kind of feeling that is uncomfortable. She got up this morning and when she stretched her arm up, she feels from her armpit to her elbow it feels like it will rip. Her skin feels like it is going to rip even when she turns, moves or twists her arm. She said that it is a uncomfortable feeling on the inside of her arm. Caller does not have the email address or address for the primary care physician to provide. She said that her first dose was in the right arm. Caller asked, does she need to worry about any of these symptoms since it is getting worse and not better?
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Achiness; Tired; lymph nodes were swollen; tingling and numbing kind of feeling; arm feels kind of swollen; tingling and numbing kind of feeling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Feb2021 09:30 (Batch/Lot number: unknown) at the age of 53 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Brand; Pfizer BioNTech, Dose=1, Location: right arm), administration date: 04Feb2021, when the patient was 53 years old, for Covid-19 Immunisation. The following information was reported: PAIN (non-serious), outcome "unknown", described as "Achiness"; FATIGUE (non-serious), outcome "unknown", described as "Tired"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "lymph nodes were swollen"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious), outcome "unknown" and all described as "tingling and numbing kind of feeling"; PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "arm feels kind of swollen". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information: Caller reported that she received the second dose of the Covid-19 Vaccine on Thursday 25Feb2021 at about 09:30. She had some symptoms for about 30 hours afterward that she said that she expected like the achiness and tired. On Friday evening, her lymph nodes were swollen under her left arm. That is where she got her shot, the left arm. Every day since since it is swollen, puffy, and painful to touch. She said that it is all the way down her arm, from her hand into her fingers, like a tingling and numbing kind of feeling that is uncomfortable. She got up this morning and when she stretched her arm up, she feels from her armpit to her elbow it feels like it will rip. Her skin feels like it is going to rip even when she turns, moves or twists her arm. She said that it is a uncomfortable feeling on the inside of her arm. Caller does not have the email address or address for the primary care physician to provide. She said that her first dose was in the right arm. Caller asked, does she need to worry about any of these symptoms since it is getting worse and not better?
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: I got the shot Friday in my left arm and it was achy, it hurt that night and the next day somewhat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 79 year-old female patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: EN6200) at the age of 79 years as single dose for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications.  The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "I got the shot Friday in my left arm and it was achy, it hurt that night and the next day somewhat". Therapeutic measures were taken as a result of pain in extremity.  Additional information: The reporter stated that she is not really, basically very healthy, few little things but very healthy. Concomitant medications included Vitamins, herbs and minerals some and try to eat healthy. The reporter stated that she got the shot Friday in her left arm and it was achy, it hurt some that night and the next day somewhat but that was it. The patient received treatment with Tylenol.  No follow-up attempts are Possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain
Clinical narrative: Left-sided neck pain described as 5/10 pain "zinging, burning, aching,"; The pain radiates down the neck to the left upper back/shoulder area, and a few times radiated down neck near injection site in left deltoid; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A 28 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 09Feb2021 14:15 (Lot number: EL3247) at the age of 28 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Eczema" (unspecified if ongoing), notes: Eczema (on hands, feet, knees). The patient took concomitant medications. The following information was reported: NECK PAIN (non-serious) with onset 10Feb2021 07:00, outcome "recovered", described as "Left-sided neck pain described as 5/10 pain "zinging, burning, aching,""; NECK PAIN (non-serious) with onset 10Feb2021 07:00, outcome "recovered", described as "The pain radiates down the neck to the left upper back/shoulder area, and a few times radiated down neck near injection site in left deltoid". The events "left-sided neck pain described as 5/10 pain "zinging, burning, aching,"" and "the pain radiates down the neck to the left upper back/shoulder area, and a few times radiated down neck near injection site in left deltoid" were evaluated at the physician office visit. Therapeutic measures were taken as a result of neck pain, neck pain.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: my brother was tired a little afterward; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the parent.  A male patient received bnt162b2 (BNT162B2), administration date 25Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "my brother was tired a little afterward".  Additional Information: Reporter brother and sister-in-law both got their first dose of the Pfizer COVID vaccine the same time as reporter did. Reporter sister-in-law didn't experience any symptoms and reporter brother was tired a little afterward  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness postural, Laboratory test, Vertigo positional
Clinical narrative: Dizziness and vertigo, when I make certain move; Dizziness and vertigo, when I make certain move; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old male patient received bnt162b2 (BNT162B2), administration date 10Feb2021 (Lot number: EL3302) at the age of 70 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE1, SINGLE , Lot Number : EL1238), administration date: 20Jan2021, when the patient was 70 years old, for covid-19 vaccination. The following information was reported: DIZZINESS POSTURAL (non-serious), VERTIGO POSITIONAL (non-serious) all with onset 11Feb2021, outcome "not recovered" and all described as "Dizziness and vertigo, when I make certain move". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dizziness postural, vertigo positional.  Additional information: On 11Feb2021, the patient started having some kind of dizziness and vertigo, when she made certain move. The patient was still experiencing but not often, only when she did some sudden movement. The patient underwent some lab test. She did some test, for physical. Not 2 weeks. That was not 2 weeks. 3-4 weeks. May be 3 weeks.  No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76 year-old female patient received bnt162b2 (BNT162B2), administration date 27Feb2021 (Lot number: EN6205) at the age of 76 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (unspecified if ongoing), notes: Verbatim: Blood pressure; "Renal failure" (unspecified if ongoing), notes: Verbatim: Kidney failure; "Arthritis" (unspecified if ongoing), notes: Verbatim: Arthritis; "Kidney problems" (unspecified if ongoing), notes: Verbatim: Kidney problems. Concomitant medication(s) included: TYLENOL ARTHRITIS taken for arthritis; ALENDRONATE; CLOPIDOGREL; VITAMIN D2; LANTUS; LEVOTHYROXINE; CARVEDILOL; PANTOPRAZOLE; VITAMIN C ACID; CALCIUM; GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE;GLUCOSAMINE SULFATE]. The following information was reported: DIARRHOEA (non-serious) with onset 28Feb2021, outcome "unknown", described as "Diarrhea". Therapeutic measures were not taken as a result of diarrhoea.  Additional Information: Other Conditions: Consumer stated, she have some kidney problems, and have one kidney and had some kidney failure 3rd stage with the other one. She had mentioned the possible side effects of pretty fairly severe diarrhea after a Pfizer shot of COVID-19. Diarrhea started on early morning of the 28Feb2021 and she think it is over now. She had the shot on Sat around noon and it started during the night around 3 am. Consumer stated, other medications as Yes but every thing is long term. She haven't had any kind of reactions from those meds and they have been like she said long term and also stated Thyroid' (not clarified further). "Insulin in the form of Lantus 10 units."  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vaccination site pain
Clinical narrative: Burning sensation in the injection site; Feeling dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 01Mar2021 (Batch/Lot number: unknown) as single dose for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Burning sensation in the injection site"; DIZZINESS (non-serious), outcome "unknown", described as "Feeling dizzy". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: intense headaches; tired for a couple of days; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 01Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID diagnosis", start date: Mar2020 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset Mar2021, outcome "unknown", described as "intense headaches"; FATIGUE (non-serious) with onset Mar2021, outcome "unknown", described as "tired for a couple of days". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Injection site discomfort, Nasopharyngitis, Sleep disorder
Clinical narrative: discomfort in arm of shot injection location.; wake up during the night while sleeping; headache; cold like symptoms; feeling hung over; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 21 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 21 years as dose number, unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INJECTION SITE DISCOMFORT (non-serious), outcome "unknown", described as "discomfort in arm of shot injection location."; SLEEP DISORDER (non-serious), outcome "unknown", described as "wake up during the night while sleeping"; HEADACHE (non-serious), outcome "unknown", described as "headache"; NASOPHARYNGITIS (non-serious), outcome "unknown", described as "cold like symptoms"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "feeling hung over".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Constipation
Clinical narrative: very constipated since vaccine injection; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 90 year-old male patient received bnt162b2 (BNT162B2), administration date 25Feb2021 (Batch/Lot number: unknown) at the age of 90 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CONSTIPATION (non-serious), outcome "not recovered", described as "very constipated since vaccine injection". Therapeutic measures were taken as a result of constipation.  Additional Information: The patient said that he took prune juice and everything as treatment but no matter how much he squeezes he can't go.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: fatigue; sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Feb2021 (Lot number: EN5318, Expiration Date: 31May2021) at the age of 54 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (1st dose, Administration time: 08:15, Lot Number: EN5318, Expiry date: 31May2021, Anatomical Location: Right arm), administration date: 26Jan2021, when the patient was 54 years old, for Covid-19 immunisation, reaction(s): "Soreness in arm", "inability to lift arm above head ", "chills", "fatigue". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 17Feb2021 14:00, outcome "unknown", described as "sore arm"; FATIGUE (non-serious) with onset 17Feb2021 18:00, outcome "unknown", described as "fatigue".  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Hyperhidrosis, Nausea
Clinical narrative: some fatigue; dizziness; nausea; slight headache; she had dry heaves for a few minutes; broke out into a sweat; This is a spontaneous report received from a contactable reporter (consumer or other non-healthcare professional).  A female patient received bnt162b2 (PFIZER-BIOTECH COVID-19 mRNA VACCINE, solution for injection), administration date 25Feb2021 09:30 (Lot number: Unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "some fatigue"; DIZZINESS (non-serious), outcome "unknown", described as "dizziness"; NAUSEA (non-serious), outcome "unknown", described as "nausea"; HEADACHE (non-serious), outcome "unknown", described as "slight headache"; RETCHING (non-serious), outcome "unknown", described as "she had dry heaves for a few minutes"; HYPERHIDROSIS (non-serious), outcome "unknown", described as "broke out into a sweat".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021240734 Same reporter, event/different patient
Sex: F
Vaccine: COVID19
Symptoms: Retching
Clinical narrative: some fatigue; dizziness; nausea; slight headache; she had dry heaves for a few minutes; broke out into a sweat; This is a spontaneous report received from a contactable reporter (consumer or other non-healthcare professional).  A female patient received bnt162b2 (PFIZER-BIOTECH COVID-19 mRNA VACCINE, solution for injection), administration date 25Feb2021 09:30 (Lot number: Unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "some fatigue"; DIZZINESS (non-serious), outcome "unknown", described as "dizziness"; NAUSEA (non-serious), outcome "unknown", described as "nausea"; HEADACHE (non-serious), outcome "unknown", described as "slight headache"; RETCHING (non-serious), outcome "unknown", described as "she had dry heaves for a few minutes"; HYPERHIDROSIS (non-serious), outcome "unknown", described as "broke out into a sweat".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021240734 Same reporter, event/different patient
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Feeling abnormal, Headache, Illness, Malaise
Clinical narrative: I came down really sick; Nightmares; Headache; I was very weak; Nausea; I don't feel as good as I was before; Night sweats; Feeling bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 85 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), intramuscular, administered in arm left, administration date 27Feb2021 (Lot number: EN6202) at the age of 85 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "COVID-19", start date: 25Dec2020 (unspecified if ongoing). Concomitant medication included: BABY ASPIRIN.  The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "I came down really sick"; NIGHTMARE (non-serious), outcome "unknown", described as "Nightmares"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; ASTHENIA (non-serious), outcome "unknown", described as "I was very weak"; NAUSEA (non-serious), outcome "unknown", described as "Nausea"; MALAISE (non-serious), outcome "unknown", described as "I don't feel as good as I was before"; NIGHT SWEATS (non-serious), outcome "unknown", described as "Night sweats"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "Feeling bad". Therapeutic measures were not taken as a result of illness, nightmare, headache, asthenia, nausea, malaise, night sweats, feeling abnormal.  No follow-up attempts are possible. No further information is expected.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Night sweats, Nightmare
Clinical narrative: I came down really sick; Nightmares; Headache; I was very weak; Nausea; I don't feel as good as I was before; Night sweats; Feeling bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 85 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), intramuscular, administered in arm left, administration date 27Feb2021 (Lot number: EN6202) at the age of 85 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "COVID-19", start date: 25Dec2020 (unspecified if ongoing). Concomitant medication included: BABY ASPIRIN.  The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "I came down really sick"; NIGHTMARE (non-serious), outcome "unknown", described as "Nightmares"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; ASTHENIA (non-serious), outcome "unknown", described as "I was very weak"; NAUSEA (non-serious), outcome "unknown", described as "Nausea"; MALAISE (non-serious), outcome "unknown", described as "I don't feel as good as I was before"; NIGHT SWEATS (non-serious), outcome "unknown", described as "Night sweats"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "Feeling bad". Therapeutic measures were not taken as a result of illness, nightmare, headache, asthenia, nausea, malaise, night sweats, feeling abnormal.  No follow-up attempts are possible. No further information is expected.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: with the first COVID-19 Vaccine, his arm was not numb, it was just sore; This is a spontaneous report received from contactable reporter (other healthcare professional).  An 82-year-old male patient received bnt162b2 (PFIZER-BIOTECH COVID-19 mRNA VACCINE, solution for injection), administered in arm left, administration date 20Jan2021 12:40 (Lot number: EL3249) at the age of 82 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "heart palpitations" (unspecified if ongoing), notes: in the past.; "neck problem" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Shingles vaccine (took last summer), for vaccination, reaction: "slight reaction". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "with the first COVID-19 Vaccine, his arm was not numb, it was just sore".  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Hypersomnia, Pain
Clinical narrative: Slept for two days; a lot of pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSOMNIA (non-serious), outcome "unknown", described as "Slept for two days"; PAIN (non-serious), outcome "unknown", described as "a lot of pain".  Additional Information: The patient reported to have a "hard time" with the vaccine and couldn't even get out of bed. The patient did not quite know what was to be done.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: every joints were aching; body was aching/ feels achy; This is a spontaneous report received from contactable reporters (healthcare professional and consumer) for a Pfizer sponsored program (141003).  A 47 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) at the age of 47 years, as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Rheumatoid Arthritis" (ongoing), notes: since the patient was 34 years old; "hair loss" (unspecified if ongoing), "thinning of nails" (unspecified if ongoing), "recurring bad acne" (ongoing), all with notes: Side effects of ongoing methotrexate oral. Concomitant medication(s) included: METHOTREXATE SODIUM taken for rheumatoid arthritis, start date: Sep2020 (ongoing); BENZOYL PEROXIDE taken for acne (ongoing). The following information was reported: ARTHRALGIA (non-serious), outcome "recovered", described as "every joints were aching"; PAIN (non-serious), outcome "recovered", described as "body was aching/ feels achy". Additional information: Events were reported as resolved after two days.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: I had just a little sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (134184). The reporter is the patient.  A 67 year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "I had just a little sore arm". It was unknown if therapeutic measures were taken as a result of pain in extremity.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report received from contactable reporter (consumer or other non-healthcare professional). The reporter is the patient.  A 69-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIOTECH COVID-19 mRNA VACCINE, solution for injection), administered in arm right, administration date 23Feb2021 (Lot number: EL6202) at the age of 69 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "primary adrenal insufficiency" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: HYDROCORTISONE; FLUDROCORTISONE; LEVOTHYROXINE; VITAMINS C; VITAMINS D3; CALCIUM CITRATE; ZYRTEC ALLERGY; FISH OIL. Past drug history included: Ceftin, reaction(s): "Ceftin: Allergy"; Ceclor, reaction(s): "Ceclor: allergy". Vaccination history included: Covid-19 vaccine (dose 1, single, lot number: EL9264, administration time: 05:15 AM, vaccine location: right arm), administration date: 01Feb2021, when the patient was 69 years old, for COVID-19 immunisation, reaction(s): "heat sensation in my right arm from my wrist to my elbow", "sore arm", "unusual feeling". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm". Additional information: The patient had no other vaccine in four weeks. Patient had no COVID prior vaccination and patient had no COVID tested post vaccination.   No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Aspiration joint, Gait disturbance, Pain in extremity
Clinical narrative: excruciating pain in my right leg and couldn't walk any further; excruciating pain in my right leg and couldn't walk any further; extracted 20 cc's of liquid from right knee; This is a spontaneous report received from contactable reporter (other non HCP). The reporter is the patient.  A 63 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Feb2021 08:00 (Lot number: EN6200) at the age of 63 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included CORTISONE; SIMVASTATIN; FOCUSFACTOR; CENTRUM SILVER +50. Vaccination history included Bnt162b2 (dose number=1, lot number=EN5318, administration time=11:00 AM, vaccine location=Left arm), administration date 28Jan2021, when the patient was 63 years old, for Covid-19 immunization, reaction of soreness in my right knee. The following information was reported PAIN IN EXTREMITY (non-serious), GAIT DISTURBANCE (non-serious) all with onset 27Feb2021, outcome recovering; ASPIRATION JOINT (non-serious) with onset 27Feb2021, outcome recovering. The events excruciating pain in my right leg and couldn't walk any further, excruciating pain in my right leg and couldn't walk any further, and extracted 20 cc's of liquid from right knee were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain in extremity, gait disturbance, aspiration joint.  Patient has no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19, and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient reported that about 2 days following the first shot on 28Jan2021, he experienced a soreness in his right knee that progressively got to the point that he couldn't apply pressure on my right leg. He eventually saw my orthopedic surgeon for an assessment and they identified some water on the knee and gave me a cortisone shot. This was the same day that patient received his 2nd vaccination on 18Feb2021. On 27Feb2021, while walking about 1.5 miles, he experienced excruciating pain in his right leg, and couldn't walk any further. He was taken to the clinic where they extracted 20 cc's of liquid from his right knee, placed in a brace and crutches, and told to take 600 mg of NSAIDS 3 times a day. Pain was now subsiding.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: metallic taste in mouth; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 01Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DYSGEUSIA (non-serious) with onset 01Mar2021, outcome "unknown", described as "metallic taste in mouth".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Inappropriate schedule of product administration
Clinical narrative: vaccine doses were administered 13 days apart; diarrhea was still continuing, 18 days after the second dose; This is a spontaneous report received from contactable consumer. The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 02Feb2021 13:15 (Lot number: EM9809) at the age of 65 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "osteoporosis" (unspecified if ongoing); "arthritis" (unspecified if ongoing); "known allergies: crabmeat" (unspecified if ongoing); "known allergies: wool" (unspecified if ongoing). Concomitant medication included: MELOXICAM. Vaccination history included: BNT162B2 (dose 1, administered in the left arm, Lot number: EL9261), administration date: 21Jan2021 13:00, when the patient was 65 years old, for COVID-19 immunisation, reactions: "stomach cramps", "ongoing daily bouts of diarrhea". The following information was reported: DIARRHOEA (non-serious) with onset 2021, outcome "not recovered", described as "diarrhea was still continuing, 18 days after the second dose"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 02Feb2021, outcome "unknown", described as "vaccine doses were administered 13 days apart". Therapeutic measures were not taken as a result of diarrhoea.  Additional information: The patient's diarrhea started on 25Jan2021 (after the first dose) and was still continuing, 18 days after the second dose. Changes in diet did not seem to help. She planned to call her doctor. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination, and she has not been tested for COVID-19 since the vaccination.   No follow up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: back pain; A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administration date 24Feb2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: BACK PAIN (non-serious), outcome "unknown", described as "back pain". Therapeutic measures were taken as a result of back pain. Additional information: The patient took tramadol due back pain. The patient wanted to know if he is allowed to continue the pain reliever.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Malaise; This is a spontaneous report received from a contactable reporter(s) (Other HCP) for a Pfizer sponsored program (159558).  A female patient received bnt162b2 (PFIZER-BIONTECH COVID-9 VACCINE) (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for COVID-19 immunisation. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "Malaise". Therapeutic measures were taken as a result of malaise.  Additional Information: The report received from a Pfizer-sponsored program. The onset of event was about 15-16 days after the 2nd dose of vaccine. The patient was treated with steroids.     No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling
Clinical narrative: very bad aches and pains; Hands were swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 03Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 04Feb2021, outcome "unknown", described as "very bad aches and pains"; PERIPHERAL SWELLING (non-serious) with onset 04Feb2021, outcome "unknown", described as "Hands were swollen".  Additional Information: The patient couldn't get out of bed because of the very bad aches and pains. The patient did not have the second scheduled but was wondering if she should get that second dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: it only hurt where the shot was given for the right arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, solution for injection), administered in arm right, administration date 20Jan2021 15:45 (Lot number: EL3246) at the age of 62 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Left Arm Hurting/Left Forearm was hurting" (unspecified if ongoing), notes: went to the doctor a couple of months ago; "Cancer" (unspecified if ongoing), notes: Cancer survivor. The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "it only hurt where the shot was given for the right arm". Additional information: The patient was doing push-ups and her jiggling triceps part under the arm was hurting. She was also doing sit-ups. The doctor told her that she might have pulled a muscle which led to her left arm hurting.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Hypersensitivity, Nasopharyngitis, Rhinorrhoea
Clinical narrative: experiencing cold or like a severe allergy; experiencing cold or like a severe allergy; her head stuck up; nose is running; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious), HYPERSENSITIVITY (non-serious), outcome "unknown" and all described as "experiencing cold or like a severe allergy"; HEAD DISCOMFORT (non-serious), outcome "unknown", described as "her head stuck up"; RHINORRHOEA (non-serious), outcome "unknown", described as "nose is running".  Additional information: Caller mentioned that she already received the first dose 2 weeks ago and is due for the second dose tomorrow. Caller is asking if she needs to reschedule the second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Drug ineffective, Suspected COVID-19
Clinical narrative: has full symptoms, the patient thought of might having Covid; has full symptoms, the patient thought of might having Covid; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. Relevant medical history included: "wasn't feeling well from the morning before receiving the vaccine" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "has full symptoms, the patient thought of might having Covid". It was unknown if therapeutic measures were taken as a result of drug ineffective, suspected COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.